Literature DB >> 25415655

A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).

Eavan G Muldoon1, Karen Switkowski, Alan Tice, David R Snydman, Geneve M Allison.   

Abstract

BACKGROUND: The use of outpatient parenteral antimicrobial therapy (OPAT) is standard medical practice; however, significant heterogeneity in practice exists. We hypothesized that formal OPAT programs are associated with increased physician participation in patient safety activities.
METHODS: United States Infectious Disease (ID) physicians were contacted and asked to participate in an electronic survey from April through June 2012. Data were analyzed using SPSS version 20.
RESULTS: In all, 3718 physicians were contacted and 316 (8.5%) responded. Respondents practice in 47 states; the majority (79%) practice adult ID, 11% pediatric ID, 10% a combination of the two. Sixty percent reported that ID consultation was not mandatory before OPAT, and 75% of these respondents thought it should be compulsory. The most common indications were osteomyelitis, prosthetic joint infections, and endocarditis, and the most common antibiotics were vancomycin, ceftriaxone, and ertapenem. Most respondents (59%) discharge patients with OPAT weekly, and have a median number of 11 OPAT patients (95% confidence interval (CI) 8.5-13.4). Half of respondents have a formal OPAT program. Fifty-two percent report no systematic method of communication between inpatient and outpatient physicians when patients are discharged with OPAT, 49% have no systematic method of lab tracking, and 34% have no method of ensuring patient adherence to clinic visits. All of these patient safety measures were more likely to be present in practice sites with formal OPAT programs (p < 0.001).
CONCLUSIONS: Opportunities exist for improving OPAT monitoring and patient safety. Formal OPAT programs provide the framework for safe and effective care and are to be encouraged.

Entities:  

Keywords:  OPAT; infectious diseases; outpatient parenteral antimicrobial therapy; patient safety; survey

Mesh:

Substances:

Year:  2014        PMID: 25415655     DOI: 10.3109/00365548.2014.967290

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  18 in total

1.  Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy.

Authors:  Kelsea Zukauckas; Russell J Benefield; Michael Newman; Laura Certain
Journal:  Antimicrob Agents Chemother       Date:  2022-05-11       Impact factor: 5.938

2.  The Impact of a Standardized Discharge Process on 30-Day Readmissions for Patients on Outpatient Parenteral Antibiotic Treatment.

Authors:  Charnicia E Huggins; Tae Eun Park; Eric Boateng; Cosmina Zeana
Journal:  Hosp Pharm       Date:  2020-12-29

Review 3.  Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Authors:  Ester Steffens; Charlotte Quintens; Inge Derdelinckx; Willy E Peetermans; Johan Van Eldere; Isabel Spriet; Annette Schuermans
Journal:  Infection       Date:  2018-11-15       Impact factor: 3.553

4.  Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy.

Authors:  Sara C Keller; Deborah Williams; Mitra Gavgani; David Hirsch; John Adamovich; Dawn Hohl; Ayse P Gurses; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 5.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

6.  Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network.

Authors:  Monica Schmidt; Bevin Hearn; Michael Gabriel; Melanie D Spencer; Lewis McCurdy
Journal:  Open Forum Infect Dis       Date:  2017-06-16       Impact factor: 3.835

7.  Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure.

Authors:  Marion Le Maréchal; Gianpiero Tebano; Annelie A Monnier; Niels Adriaenssens; Inge C Gyssens; Benedikt Huttner; Romina Milanic; Jeroen Schouten; Mirjana Stanic Benic; Ann Versporten; Vera Vlahovic-Palcevski; Veronica Zanichelli; Marlies E Hulscher; Céline Pulcini
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

Review 8.  Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.

Authors:  Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2019-08-26

9.  Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy.

Authors:  Helen T D'Couto; Gregory K Robbins; Kevin L Ard; Sarah E Wakeman; Justin Alves; Sandra B Nelson
Journal:  Open Forum Infect Dis       Date:  2018-04-18       Impact factor: 3.835

10.  Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.

Authors:  Victoria Huang; Jorg J Ruhe; Polina Lerner; Marianna Fedorenko
Journal:  BMC Pharmacol Toxicol       Date:  2018-08-06       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.